Pediatric rheumatology

Childhood-onset systemic lupus erythematosus: A descriptive and comparative study of clinical, laboratory, and treatment characteristics in two populations

LupusPublished Comparative cohort study

Authors' conclusion

Our findings suggest an earlier age of disease onset and a higher prevalence of kidney involvement in Turkish patients. Differences in treatment approaches were also noted. However, damage accrual related to SLE does not appear to be different between the two patient populations.

Study context

Population
Patients with childhood-onset systemic lupus erythematosus (SLE) fulfilling the 1997 ACR classification criteria, Turkey and the United States
Participants
174 patients
Exposure
Turkish vs U.S. childhood-onset SLE cohorts
  • Turkeyn = 108
  • U.S.n = 66
Outcome
Age at diagnosis
Methodological detailsmulticentre, descriptive and comparative
  • Multicentre
  • Descriptive and comparative

Main finding

As reported in the abstract

P < 0.001

Observational data: associations, not effects.

Further findings

OutcomeU.S.P value
PhotosensitivityTurkish cohort vs U.S. cohort21.2%P = 0.007
Renal involvementTurkish cohort vs U.S. cohort36.4%P = 0.045
Anti-Ro/SSA positivityU.S. cohort vs Turkish cohort34.8%P < 0.001
Anti-Sm positivityU.S. cohort vs Turkish cohort59.1%P < 0.001
Anti-RNP positivityU.S. cohort vs Turkish cohort47.0%P < 0.001
Current RTX useU.S. cohort vs Turkish cohort37.9%P < 0.001
Current belimumab useU.S. cohort vs Turkish cohort19.7%P < 0.001
CYC use throughout disease course (often low-dose Euro-Lupus protocol)Turkish cohort vs U.S. cohort4.5%P < 0.001
Female-to-male ratio · Turkish cohort vs U.S. cohort
P = 0.73
  • Photosensitivity: Turkish cohort 45.4%
  • Renal involvement: Turkish cohort 41.7%
  • Anti-Ro/SSA positivity: Turkish cohort 15.7%
  • Anti-Sm positivity: Turkish cohort 19.4%
  • Anti-RNP positivity: Turkish cohort 14.8%
  • Current RTX use: Turkish cohort 1.9%
  • Current belimumab use: Turkish cohort 0%
  • CYC use throughout disease course (often low-dose Euro-Lupus protocol): Turkish cohort 24.1%

Female-to-male ratio

Similar between the two cohorts (∼3:1)

SLICC/ACR DI scores

Not different between the two cohorts

Original publication

Childhood-onset systemic lupus erythematosus: A descriptive and comparative study of clinical, laboratory, and treatment characteristics in two populations. Lupus. Published 22 July 2024. doi:10.1177/09612033241265975

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.